Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4299)
All Articles published online
|
Feb 21, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Gong JF, Li J, Gao J, Sun NP, Shen L. Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients. World J Gastroenterol 2012; 18(7): 698-703 [PMID: 22363143 DOI: 10.3748/wjg.v18.i7.698] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i7/698.htm |
| Number | Citing Articles |
| 1 |
Jia‐Yu Ling, Miao‐Miao Ding, Zi‐Feng Yang, Yan‐Dong Zhao, Xiao‐Yu Xie, Li‐Shuo Shi, Huai‐Ming Wang, Wu‐Teng Cao, Jian‐Wei Zhang, Hua‐Bin Hu, Yue Cai, Hui Wang, Yan‐Hong Deng. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis. Journal of Surgical Oncology 2021; 124(8): 1442 doi: 10.1002/jso.26664
|
| 2 |
Jian Li, Lin Shen. The current status of and prospects in research regarding gastrointestinal stromal tumors in China. Cancer 2020; 126(S9): 2048 doi: 10.1002/cncr.32684
|
| 3 |
Peter Reichardt, George D. Demetri, Hans Gelderblom, Piotr Rutkowski, Seock-Ah Im, Sudeep Gupta, Yoon-Koo Kang, Patrick Schöffski, Jochen Schuette, Denis Soulières, Jean-Yves Blay, David Goldstein, Kolette Fly, Xin Huang, Massimo Corsaro, Maria Jose Lechuga, Jean-Francois Martini, Michael C. Heinrich. Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2051-5
|
| 4 |
He Yu, Raj K. Singh Badhan. The Application of Virtual Therapeutic Drug Monitoring to Assess the Pharmacokinetics of Imatinib in a Chinese Cancer Population Group. Journal of Pharmaceutical Sciences 2023; 112(2): 599 doi: 10.1016/j.xphs.2022.09.028
|
| 5 |
Bahman Amani, Sara Zareei, Behnam Amani, Mahsa Zareei, Neda Zareei, Rouhollah Shabestan, Arash Akbarzadeh. Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence. Immunity, Inflammation and Disease 2022; 10(6) doi: 10.1002/iid3.628
|
| 6 |
DONG XUE, HONGQIANG CHEN, YUXIN CHEN. Giant extragastrointestinal stromal tumor in the transverse mesocolon concomitant with gastric cancer in an elderly patient: Case report. Oncology Letters 2013; 5(2): 627 doi: 10.3892/ol.2012.1030
|
| 7 |
Ipek Özer-Stillman, Lauren Strand, Jane Chang, Ateesha F. Mohamed, Katherine E. Tranbarger-Freier. Meta-analysis for the Association between Overall Survival and Progression-Free Survival in Gastrointestinal Stromal Tumor. Clinical Cancer Research 2015; 21(2): 295 doi: 10.1158/1078-0432.CCR-14-1779
|
| 8 |
T. Reid. Reintroduction of Imatinib in GIST. Journal of Gastrointestinal Cancer 2013; 44(4): 385 doi: 10.1007/s12029-013-9532-4
|
| 9 |
Lin Tu, Peter Hohenberger, Heike Allgayer, Hui Cao. Standard Approach to Gastrointestinal Stromal Tumors - Differences between China and Europe. Visceral Medicine 2018; 34(5): 353 doi: 10.1159/000494347
|
| 10 |
Samantha C. Sodergren, Alice White, Fabio Efficace, Mirjam Sprangers, Deborah Fitzsimmons, Andrew Bottomley, Colin D. Johnson. Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group. Critical Reviews in Oncology/Hematology 2014; 91(1): 35 doi: 10.1016/j.critrevonc.2014.01.002
|
| 11 |
Jing Qi, He-Li Liu, Feng Ren, Sheng Liu, Wei Shi, Wei-Hang Liu, Gao-Qiang Cai, Guo-Qing Liao. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01840-9
|
| 12 |
Xiaolong Wu, Libo Feng, Qing Liu, Dong Xia, Liang Xu. Partial response to imatinib treatment in a patient with unresectable gastrointestinal stromal tumor: A case report and mini literature review. Experimental and Therapeutic Medicine 2016; 12(4): 2297 doi: 10.3892/etm.2016.3614
|
| 13 |
Shaoqing Huang, Xing Liu, Xiaodan Guo, Hui Wu, Huishan Lu, Zhizhong Pan, Shirong Cai, Xiaojun Wu, Xinhua Zhang. Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors – a real-world multi-center study. Translational Oncology 2023; 30: 101641 doi: 10.1016/j.tranon.2023.101641
|
| 14 |
Liang Chen, Qiang Zhang, Feng-Yuan Li, Li Yang, Dian-Cai Zhang, Lin-Jun Wang, Wei-Zhi Wang, Zheng Li, Jiang-Hao Xu, Zhong-Yuan He, Kang-Jing Xu, Ming Chen, Hao Xu, Ze-Kuan Xu. Comparison of treatment outcomes between laparoscopic and endoscopic surgeries for relatively small gastric gastrointestinal stromal tumors. Surgical Oncology 2018; 27(4): 737 doi: 10.1016/j.suronc.2018.10.002
|
| 15 |
Deborah van de Wal, Mai Elie, Axel Le Cesne, Elena Fumagalli, Dide den Hollander, Robin L. Jones, Gloria Marquina, Neeltje Steeghs, Winette T. A. van der Graaf, Olga Husson. Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature. Cancers 2022; 14(7): 1832 doi: 10.3390/cancers14071832
|
| 16 |
Jia-Qing Zhu, Wen-Bin Ou. Therapeutic targets in gastrointestinal stromal tumors. World Journal of Translational Medicine 2015; 4(1): 25-37 doi: 10.5528/wjtm.v4.i1.25
|
| 17 |
Zhi Dong, Jing Gao, Jifang Gong, Jie Li, Yanyan Li, Lin Shen, Jian Li. Clinical benefit of sunitinib in gastrointestinal stromal tumors with different exon 11 mutation genotypes. Future Oncology 2017; 13(23): 2035 doi: 10.2217/fon-2017-0252
|
| 18 |
Hao Xu, Qi Liu. Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors. OncoTargets and Therapy 2021; : 13345 doi: 10.2147/OTT.S279998
|
| 19 |
Moshe C. Ornstein, Laura Wood, Paul Elson, Kimberly Allman, Jennifer Beach, Allison Martin, Timothy Gilligan, Jorge A. Garcia, Brian I. Rini. Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2017; 15(2): e275 doi: 10.1016/j.clgc.2016.08.014
|